Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
| Autor: | Ramakrishnan, Sanjay a, b, Russell, Richard E K b, d, Mahmood, Hafiz R a, Krassowska, Karolina b, Melhorn, James b, Mwasuku, Christine b, Pavord, Ian D b, Bermejo-Sanchez, Laura b, Howell, Imran b, Mahdi, Mahdi b, Peterson, Stefan e, Bengtsson, Thomas e, Bafadhel, Mona c, d, * |
|---|---|
| Zdroj: | In The Lancet Respiratory Medicine January 2025 13(1):59-68 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|